Logo image of SGHC

SUPER GROUP SGHC LTD (SGHC) Stock Fundamental Analysis

NYSE:SGHC - GG00BMG42V42 - Common Stock

11.56 USD
+0.53 (+4.81%)
Last: 9/3/2025, 8:04:01 PM
11.66 USD
+0.1 (+0.87%)
Pre-Market: 9/4/2025, 7:20:11 AM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SGHC. SGHC was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. SGHC has only an average score on both its financial health and profitability. SGHC is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes SGHC very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SGHC had positive earnings in the past year.
Of the past 5 years SGHC 4 years were profitable.
SGHC had a positive operating cash flow in each of the past 5 years.
SGHC Yearly Net Income VS EBIT VS OCF VS FCFSGHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.53%, SGHC belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
SGHC has a Return On Equity of 21.09%. This is in the better half of the industry: SGHC outperforms 79.10% of its industry peers.
The Return On Invested Capital of SGHC (30.55%) is better than 96.27% of its industry peers.
SGHC had an Average Return On Invested Capital over the past 3 years of 15.79%. This is in line with the industry average of 16.00%.
The 3 year average ROIC (15.79%) for SGHC is below the current ROIC(30.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.53%
ROE 21.09%
ROIC 30.55%
ROA(3y)10.16%
ROA(5y)16.96%
ROE(3y)17.87%
ROE(5y)59.56%
ROIC(3y)15.79%
ROIC(5y)31.82%
SGHC Yearly ROA, ROE, ROICSGHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

Looking at the Profit Margin, with a value of 7.02%, SGHC is in the better half of the industry, outperforming 61.94% of the companies in the same industry.
In the last couple of years the Profit Margin of SGHC has declined.
SGHC's Operating Margin of 14.22% is fine compared to the rest of the industry. SGHC outperforms 67.91% of its industry peers.
SGHC's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.22%
PM (TTM) 7.02%
GM N/A
OM growth 3Y-8.81%
OM growth 5YN/A
PM growth 3Y-28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGHC Yearly Profit, Operating, Gross MarginsSGHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SGHC is creating value.
Compared to 1 year ago, SGHC has more shares outstanding
The number of shares outstanding for SGHC has been increased compared to 5 years ago.
The debt/assets ratio for SGHC is higher compared to a year ago.
SGHC Yearly Shares OutstandingSGHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SGHC Yearly Total Debt VS Total AssetsSGHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 11.18 indicates that SGHC is not in any danger for bankruptcy at the moment.
SGHC has a better Altman-Z score (11.18) than 96.27% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that SGHC is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.11, SGHC belongs to the best of the industry, outperforming 81.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 11.18
ROIC/WACC3.39
WACC9%
SGHC Yearly LT Debt VS Equity VS FCFSGHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 1.42 indicates that SGHC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.42, SGHC is in the better half of the industry, outperforming 70.90% of the companies in the same industry.
A Quick Ratio of 1.42 indicates that SGHC should not have too much problems paying its short term obligations.
SGHC has a better Quick ratio (1.42) than 73.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
SGHC Yearly Current Assets VS Current LiabilitesSGHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

SGHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 127.13%, which is quite impressive.
SGHC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.17% yearly.
Looking at the last year, SGHC shows a quite strong growth in Revenue. The Revenue has grown by 18.20% in the last year.
The Revenue has been growing by 28.06% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)127.13%
EPS 3Y-21.17%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)18.2%
Revenue growth 3Y5.54%
Revenue growth 5Y28.06%
Sales Q2Q%41.7%

3.2 Future

Based on estimates for the next years, SGHC will show a very strong growth in Earnings Per Share. The EPS will grow by 40.64% on average per year.
Based on estimates for the next years, SGHC will show a quite strong growth in Revenue. The Revenue will grow by 12.77% on average per year.
EPS Next Y56.69%
EPS Next 2Y54.6%
EPS Next 3Y40.64%
EPS Next 5YN/A
Revenue Next Year21.82%
Revenue Next 2Y15.24%
Revenue Next 3Y12.77%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SGHC Yearly Revenue VS EstimatesSGHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
SGHC Yearly EPS VS EstimatesSGHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 38.53, SGHC can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of SGHC is on the same level as its industry peers.
SGHC's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.84.
SGHC is valuated correctly with a Price/Forward Earnings ratio of 16.38.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SGHC indicates a somewhat cheap valuation: SGHC is cheaper than 69.40% of the companies listed in the same industry.
SGHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38.53
Fwd PE 16.38
SGHC Price Earnings VS Forward Price EarningsSGHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

SGHC's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.48
SGHC Per share dataSGHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

SGHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGHC has a very decent profitability rating, which may justify a higher PE ratio.
SGHC's earnings are expected to grow with 40.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y54.6%
EPS Next 3Y40.64%

More info and screens

2

5. Dividend

5.1 Amount

SGHC has a Yearly Dividend Yield of 1.34%. Purely for dividend investing, there may be better candidates out there.
SGHC's Dividend Yield is a higher than the industry average which is at 4.09.
Compared to an average S&P500 Dividend Yield of 2.32, SGHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.34%

5.2 History

SGHC is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SGHC Yearly Dividends per shareSGHC Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y54.6%
EPS Next 3Y40.64%
SGHC Yearly Income VS Free CF VS DividendSGHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

More info and screens

SUPER GROUP SGHC LTD

NYSE:SGHC (9/3/2025, 8:04:01 PM)

Premarket: 11.66 +0.1 (+0.87%)

11.56

+0.53 (+4.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners9.11%
Inst Owner Change26.99%
Ins Owners4.59%
Ins Owner ChangeN/A
Market Cap5.85B
Analysts84.62
Price Target15.59 (34.86%)
Short Float %3.89%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 1.34%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date06-23 2025-06-23 (0.04)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.39%
Min EPS beat(2)-23.38%
Max EPS beat(2)10.61%
EPS beat(4)2
Avg EPS beat(4)-4.12%
Min EPS beat(4)-24.38%
Max EPS beat(4)20.66%
EPS beat(8)4
Avg EPS beat(8)52.32%
EPS beat(12)5
Avg EPS beat(12)27.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.51%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)8.12%
Revenue beat(4)2
Avg Revenue beat(4)2.66%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)8.12%
Revenue beat(8)6
Avg Revenue beat(8)4.69%
Revenue beat(12)9
Avg Revenue beat(12)4.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.08%
PT rev (3m)44.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.26%
EPS NY rev (1m)-15.38%
EPS NY rev (3m)-15.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.66%
Revenue NY rev (1m)1.99%
Revenue NY rev (3m)3.5%
Valuation
Industry RankSector Rank
PE 38.53
Fwd PE 16.38
P/S 3.01
P/FCF N/A
P/OCF N/A
P/B 9.06
P/tB 16.24
EV/EBITDA 15.48
EPS(TTM)0.3
EY2.6%
EPS(NY)0.71
Fwd EY6.11%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.83
BVpS1.28
TBVpS0.71
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.53%
ROE 21.09%
ROCE 38.67%
ROIC 30.55%
ROICexc 60.17%
ROICexgc 282.89%
OM 14.22%
PM (TTM) 7.02%
GM N/A
FCFM N/A
ROA(3y)10.16%
ROA(5y)16.96%
ROE(3y)17.87%
ROE(5y)59.56%
ROIC(3y)15.79%
ROIC(5y)31.82%
ROICexc(3y)34.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.99%
ROCE(5y)40.28%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.96%
ROICexc growth 5YN/A
OM growth 3Y-8.81%
OM growth 5YN/A
PM growth 3Y-28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 0.19
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 11.18
F-ScoreN/A
WACC9%
ROIC/WACC3.39
Cap/Depr(3y)74.88%
Cap/Depr(5y)56.11%
Cap/Sales(3y)3.76%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)127.13%
EPS 3Y-21.17%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y56.69%
EPS Next 2Y54.6%
EPS Next 3Y40.64%
EPS Next 5YN/A
Revenue 1Y (TTM)18.2%
Revenue growth 3Y5.54%
Revenue growth 5Y28.06%
Sales Q2Q%41.7%
Revenue Next Year21.82%
Revenue Next 2Y15.24%
Revenue Next 3Y12.77%
Revenue Next 5YN/A
EBIT growth 1Y187.07%
EBIT growth 3Y-3.76%
EBIT growth 5YN/A
EBIT Next Year99.73%
EBIT Next 3Y36.11%
EBIT Next 5YN/A
FCF growth 1Y142.01%
FCF growth 3Y-1.1%
FCF growth 5Y295.28%
OCF growth 1Y113.54%
OCF growth 3Y7.33%
OCF growth 5Y137.97%